Atlas Trials

TaiRx, Inc.

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch TaiRx, Inc.

RecordFirmDate
A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC (NCT07521852)TaiRx, Inc.2026-03-31
Study of TRX-920 for Patients With Advanced Solid Tumors (NCT06143774)TaiRx, Inc.2023-10-31
CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma (NCT05257590)TaiRx, Inc.2022-05-23
Safety and Pharmacokinetic Study of CVM-1118 Extended-Release in Advanced Cancer Patients (NCT04336124)TaiRx, Inc.2020-05-25
Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors (NCT03600233)TaiRx, Inc.2018-12-15
CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma (NCT03582618)TaiRx, Inc.2018-07-12

Track TaiRx, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.